Blood monocyte phenotypes and soluble endotoxin receptor CD14 in systemic inflammatory diseases and patients with chronic renal failure

Nephrology Dialysis Transplantation

Volumn 15, Issue 5, 2000, Pages 574-578

  Scherberich, Juergen E ^a,c   Nockher, Wolfgang A ^b  

^a UNIVERSITY OF MUNICH   (Germany)

^b Institute of Clinical Chemistry   (Germany)

^c Abteilung fur Neurologie Stroke Unit Stad Krankenhaus Munchen Harlaching   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

CALCITRIOL; CD14 ANTIGEN; CD16 ANTIGEN; DEXAMETHASONE; DIFFERENTIATION ANTIGEN; ENDOTOXIN; GLUCOCORTICOID; HYDROCORTISONE; PREDNISOLONE; RECEPTOR;

ANTIGEN PRESENTATION; APOPTOSIS; CELL ACTIVATION; CHRONIC KIDNEY FAILURE; DISEASE PREDISPOSITION; DOSE RESPONSE; EDITORIAL; HEMODIALYSIS; HUMAN; IMMUNE RESPONSE; INFLAMMATION; MACROPHAGE; MONOCYTE; PERITONEAL DIALYSIS; PHENOTYPE; PRIORITY JOURNAL;

EID: 0034061993     PISSN: 09310509     EISSN: None     Source Type: Journal    
DOI: 10.1093/ndt/15.5.574     Document Type: Editorial

References (25)

1. Descamps-Latscha B, Herbelin A, Nguyen AT et al. Soluble CD23 as an effector of immune dysregulation in chronic uremia and dialysis. Kidney Int 1993; 43: 878-884
2. Matsumoto Y, Shinzato T, Takai I et al. Peripheral deletion of γδ T cells in haemodialysis patients. Nephrol Dial Transplant 1998; 13: 2861-2866
3. Zimmermann J, Herrlinger S, Pruy A, Metzger T, Wanner C. Inflammation enhances cardiovascular risk and mortality in hemodialysis patients. Kidney Int 1999; 55: 648-658
4. Lazarus JM, Owen WF. Role of bioincompatibility in dialysis morbidity and mortality. Am J Kidney Dis 1994; 24: 1019-1032
5. Lonnemann G, Linneweber S, Burg M, Koch KM. Transfer of endogenous pyrogens across artificial membranes? Kidney Int 1998; 53 [Suppl. 66]: S43-S46
6. Nockher WA, Scherberich JE. Monocyte cell surface CD14 expression and soluble CD14 antigen in hemodialysis: evidence for chronic exposure to LPS. Kidney Int 1995; 48: 1469-1475
7. Scherberich JE, Nockher WA. CD14 + + monocytes, CD14+/CD16+ subset and soluble CD14 as biological markers of inflammatory diseases and monitoring immunosuppressive therapy. Clin Chem Lab Med 1999; 37: 209-213
8. Scherberich JE, Nockher WA. Monocyte LPS receptor (CD14), CD14+/CD16+, HLA-DR expression and soluble CD14 (sCD14) in patients with acute and chronic infections and under acute and chronic immunosuppression. In: Faist A, ed. The Immune Consequences of Trauma, Shock and Sepsis, Monduzzi Editore, Bologna, 1997; 339-344
9. Nockher WA, Scherberich JE. Expression and release of the monocyte lipopolysaccharide receptor antigen CD14 are suppressed by glucocorticoids in vivo and in vitro. J Immunol 1997; 158: 501-506
10. Ziegler-Heitbrock HWL. Heterogeneity of human blood monocytes: the CD14+CD16+ subpopulation. Immunol Today 1996; 17: 424-428
11. Nockher WA, Scherberich JE. Expanded CD14+/CD16+ monocyte subpopulation in patients with acute and chronic infections undergoing hemodialysis. Infect Immun 1998; 66: 2787-2790
12. Nockher WA, Wigand R, Schoeppe W, Scherberich JE. Elevated levels of soluble CD14 in serum of patients with systemic lupus erythematosus. Clin Exp Immunol 1994; 96: 15-19
13. Nockher WA, Bergmann L, Scherberich JE. Increased soluble CD14 serum levels and altered CD14 expression of peripheral blood monocytes in HIV-infected patients. Clin Exp Immunol 1994; 98: 369-374
14. Girndt M, Sester U, Kaul H, Köhler H. Production of proinflammatory and regulatory monokines in hemodialysis patients shown at a single-cell level. J Am Soc Nephrol 1998; 9: 1689-1696
15. Wiemer J, Nockher WA, Scherberich JE. Increase in CD14 expression during hemodialysis procedure depends on dialysate fluid quality. Kidney Blood Press Res 1999; 22: 291
16. Brauner A, Lu Y, Hallden G, Hylander B, Lundahl L. Difference in the blood monocyte phenotype between uremic patients and healthy controls: its relation to monocyte differentiation into macrophages in the peritoneal cavity. Inflammation 1998; 22: 55-66
17. Jedlicka J, Segerer W, Scherberich JE. Comparative analysis of leucocyte endotoxin receptor expression in patients under CAPD or chronic haemodialysis treatment. Kidney Blood Press Res 1998; 21: 199-200
18. Glorieux G, Hsu CH, de Smet R et al. Inhibition of calcitriol-induced monocyte CD14-expression by uremic toxins: role of purines. J Am Soc Nephrol 1998; 9: 1826-1831
19. Devitt A, Moffatt OD, Raykundalia C, Capra JD, Simmons DL, Gregory CD. Human CD14 mediates recognition and phagocytosis of apoptotic cells. Nature 1998; 392: 505-509
20. Heidenreich S. Monocyte CD14: a multifunctional receptor engaged in apoptosis from both sides. J Leukoc Biol 1999; 65: 737-743
21. Scherberich JE, Nockher WA, Baer PC. Cross-talk between activated tubular epithelia of human kidney and monocytes: a basis for target cell specific pharmacotherapy? Nephrol Dial Transplant 1999; 14 [Suppl 4]: 8-10
22. Baer PC, Nockher WA, Haase W, Scherberich JE. Isolation of proximal and distal tubule cells from human kidney by immuno-magnetic separation. Kidney Int 1997; 52: 1321-1331
23. Abbate M, Remuzzi G. Proteinuria as a mediator of tubulointerstitial injury. Kidney Blood Press Res 1999; 22: 37-46
24. Scherberich JE, Schneider J. Nockher WA, Schoeppe W. Excretion of a soluble 48 kDa monocyte membrane antigen in patients with kidney diseases. Kidney Int 1993; 43: 249
25. Hotta O, Yusa N, Ooyama M, Unno K, Furata T, Taguma Y. Detection of urinary macrophages expressing the CD16 (FcγRIII) molecule: a novel marker of acute inflammatory glomerular injury. Kidney Int 1999; 55: 1927-1934